Please use this identifier to cite or link to this item:
https://hdl.handle.net/1/1414| Title: | New agents for orthopaedic thromboprophylaxis: caution essential, but time will tell | Authors: | Verma, Abhishek K | Issue Date: | Nov-2009 | Source: | Volume 79, Issue 11, pp. 773 - 774 | Journal title: | ANZ Journal of Surgery | Department: | Haematology | Abstract: | This article discusses two new agents, Dabigatran and Rivaroxaban and their use in orthopaedic thromboprophylaxis. Their safety, efficacy and cost effectiveness is also discussed. | URI: | https://elibrary.cclhd.health.nsw.gov.au/cclhdjspui/handle/1/1414 | DOI: | 10.1111/j.1445-2197.2009.05099.x | Pubmed: | https://www.ncbi.nlm.nih.gov/pubmed/20078521 | Publicaton type: | Journal Article | Keywords: | Drug Therapy |
| Appears in Collections: | Health Service Research |
Show full item record
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.